Biomedical Engineering Reference
In-Depth Information
reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats. J Biol
Chem 271:15091-15098.
89. Toh S, Wada M, Uchiumi T, Inokuchi A, Makino Y, Horie Y, Adachi Y, Sakisaka S,
Kuwano M. 1999. Genomic structure of the canalicular multispecific organic anion-
transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in
Dubin-Johnson syndrome. Am J Hum Genet 64:739-746.
90. Hashimoto K, Uchiumi T, Konno T, Ebihara T, Nakamura T, Wada M, Sakisaka S,
Maniwa F, Amachi T, Ueda K, Kuwano M. 2002. Trafficking and functional defects
by mutations of the ATP-binding domains in MRP2 in patients with Dubin-Johnson
syndrome. Hepatology 36:1236-1245.
91. Mor-Cohen R, Zivelin A, Rosenberg N, Shani M, Muallem S, Seligsohn U. 2001. Identi-
fication and functional analysis of two novel mutations in the multidrug resistance protein
2 gene in Israeli patients with Dubin-Johnson syndrome. J Biol Chem 276:36923-36930.
92. Keitel V, Nies AT, Brom M, Hummel-Eisenbeiss J, Spring H, Keppler D. 2003. A common
Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of
MRP2 (ABCC2). Am J Physiol Gastrointest Liver Physiol 284:G165-G174.
93. Hulot JS, Villard E, Maguy A, Morel V, Mir L, Tostivint I, William-Faltaos D, Fernandez
C, Hatem S, Deray G, et al. 2005. A mutation in the drug transporter gene ABCC2
associated with impaired methotrexate elimination. Pharmacogenet Genom 15:277-
285.
94. Hirouchi M, Suzuki H, Itoda M, Ozawa S, Sawada J, Ieiri I, Ohtsubo K, Sugiyama Y.
2004. Characterization of the cellular localization, expression level, and function of SNP
variants of MRP2/ABCC2. Pharm Res 21:742-748.
95. Dean M, Rzhetsky A, Allikmets R. 2001. The human ATP-binding cassette (ABC) trans-
porter superfamily. Genome Res 11:1156-1166.
96. Ilias A, Urban Z, Seidl TL, Le Saux O, Sinko E, Boyd CD, Sarkadi B, Varadi A. 2002. Loss
of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of
human ABCC6 (MRP6). J Biol Chem 277:16860-16867.
97. Mizuarai S, Aozasa N, Kotani H. 2004. single-nucleotide polymorphisms result in
impaired membrane localization and reduced atpase activity in multidrug transporter
ABCG2. Int J Cancer 109:238-246.
98. Wang Z, Wang B, Tang K, Lee EJ, Chong SS, Lee CG. 2005. A functional polymorphism
within the MRP1 gene locus identified through its genomic signature of positive selection.
Hum Mol Genet 14:2075-2087.
99. Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W. 2005. Multidrug resistance
polypeptide 1 (MDR1, ABCB1) variant 3435C
>
T affects mRNA stability. Pharmaco-
genet Genom 15:693-704.
100. Karpati G, Carpenter S, Engel AG, Watters G, Allen J, Rothman S, Klassen G, Mamer OA.
1975. The syndrome of systemic carnitine deficiency: clinical, morphologic, biochemical,
and pathophysiologic features. Neurology 25:16-24.
101. Shoji Y, Koizumi A, Kayo T, Ohata T, Takahashi T, Harada K, Takada G. 1998. Evidence
for linkage of human primary systemic carnitine deficiency with D5S436: a novel gene
locus on chromosome 5q. Am J Hum Genet 63:101-108.
102. Nezu J, Tamai I, Oku A, Ohashi R, Yabuuchi H, Hashimoto N, Nikaido H, Sai Y, Koizumi
A, Shoji Y, et al. 1999. Primary systemic carnitine deficiency is caused by mutations in
a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91-94.
Search WWH ::
Custom Search